Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2023-08-03 Interim / Quarterly Rep…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Ajooni Biotech Limited dated August 3, 2023, addressed to the National Stock Exchange of India. It reports the outcome of a Board Meeting held on the same day, where the Board approved the un-audited financial results for the quarter ended June 30, 2023, along with the limited review report from the auditor. The document includes detailed financial data such as income, expenses, profit/loss, and assets and liabilities for the quarter. It also mentions corporate actions like increase in authorized share capital, appointment of scrutinizer for the upcoming AGM, and details about the 13th Annual General Meeting. The presence of actual financial statements and substantive financial data for the quarter indicates this is a quarterly financial report. The document is not merely an announcement of a report or a certification but contains the financial results themselves. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-08-03 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notification addressed to the stock exchange about an upcoming Board Meeting scheduled for August 3, 2023. It lists agenda items such as approval of unaudited financial results for the quarter ended June 30, 2023, increase in authorized share capital, approval of the Director's Report for FY 2022-23, and arrangements for the 13th Annual General Meeting. The document is an announcement of a board meeting and does not contain actual financial statements or detailed reports. It is not a full financial report, earnings release, or regulatory filing of results. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2023-07-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to the National Stock Exchange of India, informing that the company's website is updated and functional as per regulatory requirements (SEBI LODR Regulations, 2015). It is an undertaking or notification rather than a financial report or detailed filing. The document length is only 1169 characters, indicating it is a brief announcement. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, or other detailed filings. This fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-07 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate submitted pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2023. It is a formal certificate from the Registrar and Transfer Agent (RTA) confirming dematerialisation of securities and related compliance. The document is short (2821 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or any report content. It is a regulatory filing related to securities regulations and compliance. Therefore, it fits best under Regulatory Filings (RNS).
2023-07-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from Ajooni Biotech Limited addressed to the National Stock Exchange of India. It informs about the closure of the trading window in compliance with SEBI regulations ahead of the announcement of the company's un-audited financial results for the quarter ended June 30, 2023. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement related to insider trading restrictions before a financial results announcement. The document length is only 1728 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-30 English
Updates
Director's Dealing Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India regarding a rectification of a previously submitted disclosure under SEBI regulations related to insider trading and substantial acquisition of shares. It corrects the number of shares disposed of by a promoter group entity. The content focuses on insider trading disclosures and share transactions by a promoter group, which aligns with reporting of personal share transactions by company insiders. The document is not a financial report, earnings release, or management discussion, nor is it an announcement of a meeting or voting results. It is specifically about correcting insider share transaction disclosures, which fits the category of Director's Dealing (DIRS). The document length is short and it is a direct disclosure, not a report publication or regulatory filing of a different nature.
2023-06-22 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.